Archives for June 4, 2003

← 2003

New science chief at METabolic EXplorer

METabolic EXplorer, a French biotechnology company specialising in the development and production of new biological processes for the manufacturing of chemicals and pharmaceuticals, has bolstered its scientific team with the appointment of Philippe...

Xenova to make cancer vaccine for Pharmexa

Xenova of the UK has been awarded a two-year contract by Sweden's Pharmexa for the manufacture of a vaccine in clinical trials as a treatment for breast cancer and other tumours.

Schering-Plough cuts deal with FDA on production

Schering-Plough has reached an agreement with the US Food and Drug Administration to correct the firm's manufacturing compliance problems, which led to a $500 million fine last year.

CLL Biopharma bought by US firm

France's CLL Pharma, a specialist in drug reformulations and novel delivery technologies, has been acquired by US company Neuro Bioscience.

Baxter to invest $100m in parenterals plant

Baxter Healthcare of the US says it is planning a seven-year, $100 million (€85m) expansion of its parenteral contract manufacturing services for pharma and biotech companies.

New ink jet printer for pharma, food packaging

Trident has launched a new ink jet printing system, called SolidJet, that is specially designed to print packaging for pharmaceutical, food and beverage, and personal care products.

'Biobucks' make a return as Schroder raises $402m

Schroder Ventures Life Sciences has raised $402 million (€344m) for its biotechnology investment fund, providing a signal that venture capital may at last be turning its head back in the direction of the sector.